John T. Bingle
Plus aucun poste en cours
Profil
John T.
Bingle worked as a Treasurer at Ferro Corp.
from 2016 to 2017 and at Pfanstiehl, Inc. He holds an MBA from Carnegie Mellon University and an undergraduate degree from Rose-Hulman Institute of Technology, Inc.
Anciens postes connus de John T. Bingle
| Sociétés | Poste | Fin |
|---|---|---|
| FERRO CORPORATION | Investor Relations Contact | 20/10/2016 |
Pfanstiehl, Inc.
 Pfanstiehl, Inc. Pharmaceuticals: MajorHealth Technology Pfanstiehl, Inc. develops endotoxin injectable formulation and pharmaceutical ingredients. The firm specializes in isolation, purification, custom synthesis and scale-up development of regulated, high purity and low endotoxin injectable formulation ingredients, pharmaceutical intermediates and active pharmaceutical ingredients. The company was founded by Carl A. Pfanstiehl in 1919 and is headquartered in Waukegan, IL. | Treasurer | - |
Formation de John T. Bingle
| Carnegie Mellon University | Masters Business Admin |
| Rose-Hulman Institute of Technology, Inc. | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Ferro Corp.
 Ferro Corp. Industrial SpecialtiesProcess Industries Ferro Corp. engages in the business of manufacturing specialty materials. Its products include frits, porcelain and other glass enamels, glazes, stains, decorating colors, pigments, inks, polishing materials, dielectrics, electronic glasses and other specialty coatings. The company was founded by Harry D. Cushman, Raymond Williams, and Henry Luebbert in 1919 and is headquartered in Mayfield Heights, OH. | Process Industries |
Pfanstiehl, Inc.
Pfanstiehl, Inc. Pharmaceuticals: MajorHealth Technology Pfanstiehl, Inc. develops endotoxin injectable formulation and pharmaceutical ingredients. The firm specializes in isolation, purification, custom synthesis and scale-up development of regulated, high purity and low endotoxin injectable formulation ingredients, pharmaceutical intermediates and active pharmaceutical ingredients. The company was founded by Carl A. Pfanstiehl in 1919 and is headquartered in Waukegan, IL. | Health Technology |
